AstraZeneca–HUTCHMED FDA Filing | Lucid Diligence Brief
This Lucid Diligence Brief explores AstraZeneca’s ORPATHYS and TAGRISSO FDA…
Samsung Bioepis and Teva Expand SB41 and SB44 Biosimilar Partnership | Lucid Diligence Brief
This Lucid Diligence Brief explores Samsung Bioepis’ expansion of its…
Merck–SciBrunch SPR2015: A $400M Preclinical Bet | Lucid Diligence Brief
This Lucid Diligence Brief examines Merck’s licensing deal for SciBrunch’s…
Nanexa–Novo Nordisk PharmaShell Deal: From Validation to Development | Lucid Diligence Brief
This Lucid Diligence Brief examines the Nanexa–Novo Nordisk PharmaShell deal…
Basecamp Research $140M Series C: The Translation Test | Lucid Diligence Brief
This Lucid Diligence Brief examines Basecamp Research’s $140M Series C and…
QC Healthcare–Sanguina Collaboration: Can Digital Biomarkers Scale? | Lucid Diligence Brief
This Lucid Diligence Brief examines the QC Healthcare–Sanguina digital…
AbbVie–Iambic AI Drug Discovery Collaboration: Strategic Implications | Lucid Diligence Brief
This Lucid Diligence Brief examines the AbbVie–Iambic AI drug discovery…
Lundbeck Expands EVERSANA AI Commercialization | Lucid Diligence Brief
Lundbeck Expands EVERSANA AI Across Its U.S. Commercial Organization…
Conavi Medical Raises C$10 Million in Public Offering | Lucid Diligence Brief
Conavi Medical’s C$10M Financing Puts Novasight U.S. Adoption and Funding…
Insulinova Partners with Ospedale San Raffaele | Lucid Diligence Brief
Avaí Bio and Insulinova Test Encapsulated Beta Cells With San Raffaele as…
Curium Lantheus Merger | Lucid Diligence Brief
Curium’s proposed acquisition of Lantheus reshapes the radiopharmaceutical…
Genprex Roche Diagnostics TROP2 Collaboration | Lucid Diligence Brief
Genprex and Roche Diagnostics begin TROP2 assay validation to support…